Craig Collins struggled with his condition before committing to the long path through surgeries—and fitness—to muscle up.
Eli Lilly said it received Food and Drug Administration approval for its treatment for moderate to severely-active Crohn’s ...
The U.S. Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely ...
Eating a Mediterranean-style diet can help people manage IBD symptoms, and a new cookbook from Crohn's & Colitis Ireland ...
Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Omvoh® ...
Eli Lilly has received approval from the US Food and Drug Administration (FDA) for Omvoh (mirikizumab-mrkz) to treat ...
The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second ...
Wearable devices can identify, differentiate, and predict flare-ups, or the worsening of symptoms and inflammation, in ...
Eli Lilly (LLY) announced that the FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease in adults. Omvoh ...
Mirikizumab is a humanized immunoglobulin G4 monoclonal antibody that selectively binds to the p19 subunit of human interleukin (IL)-23.
Jane Searfoss was inspired to become a child life specialist at Boston Children's Hospital because of her own experience ...
LOS ANGELES, Jan. 15, 2025 (GLOBE NEWSWIRE) -- (“Trethera”), a clinical stage biopharmaceutical company committed to ...